​It’s not easy to get depression-detecting AI through the FDA 

​It’s not easy to get depression-detecting AI through the FDA 

A vintage computer on a background of 1s and 0s with a brain on the screen representing AI

For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person’s speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. Some elements may even find a second life beyond healthcare, like detecting deepfake audio.

Mental health assessments still largely rely on patient questionnaires and clinical interviews, rather than the lab tests or scans common in physical medicine. Instead of focusing on what someone is saying, Kintsugi’s software analyzes how it is being said. Th …

Read the full story at The Verge.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

You might also like...

​Verge subscribers: Join us for a movie night in New York City, hosted by The Vergecast 

​Verge subscribers: Join us for a movie night in New…

​ The Vergecast is hosting a special in-person screening of Sneakers in partnership with IFC…

​OpenAI just bought TBPN 

​OpenAI just bought TBPN 

​ OpenAI has purchased TBPN, an online talk show that often interviews AI executives and…

​Elon Musk is about to be a very busy boy! 

​Elon Musk is about to be a very busy boy! 

​ To be honest, I thought Elon Musk would confidentially file for SpaceX’s IPO on…